- Home
- CE vs ACLX Comparison
CE vs ACLX Comparison
Compare CE & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CE
- ACLX
- Stock Information
- Founded
- CE 1918
- ACLX 2015
- Country
- CE United States
- ACLX United States
- Employees
- CE N/A
- ACLX N/A
- Industry
- CE Major Chemicals
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- CE Industrials
- ACLX Health Care
- Exchange
- CE Nasdaq
- ACLX Nasdaq
- Market Cap
- CE 4.5B
- ACLX 4.4B
- IPO Year
- CE 2005
- ACLX 2022
- Fundamental
- Price
- CE $38.11
- ACLX $85.95
- Analyst Decision
- CE Buy
- ACLX Strong Buy
- Analyst Count
- CE 18
- ACLX 12
- Target Price
- CE $58.67
- ACLX $113.08
- AVG Volume (30 Days)
- CE 1.6M
- ACLX 530.0K
- Earning Date
- CE 11-06-2025
- ACLX 11-07-2025
- Dividend Yield
- CE 0.30%
- ACLX N/A
- EPS Growth
- CE N/A
- ACLX N/A
- EPS
- CE N/A
- ACLX N/A
- Revenue
- CE $9,939,000,000.00
- ACLX $56,979,000.00
- Revenue This Year
- CE N/A
- ACLX N/A
- Revenue Next Year
- CE $2.15
- ACLX $220.95
- P/E Ratio
- CE N/A
- ACLX N/A
- Revenue Growth
- CE N/A
- ACLX N/A
- 52 Week Low
- CE $36.29
- ACLX $47.86
- 52 Week High
- CE $129.07
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- CE 36.89
- ACLX 54.93
- Support Level
- CE $40.58
- ACLX $84.85
- Resistance Level
- CE $44.17
- ACLX $88.58
- Average True Range (ATR)
- CE 1.59
- ACLX 3.27
- MACD
- CE -0.02
- ACLX -0.55
- Stochastic Oscillator
- CE 0.00
- ACLX 28.96
About CE Celanese Corporation
Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.